Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Wang

Showing results (151-160 of 190) with videos related to

Pageof 19
Sort By:
Nature Communications|May 3, 2020
Effective combinatorial immunotherapy for penile squamous cell carcinomaTianhe Huang, Xi Cheng, Jad Chahoud, et al.
Nature|February 7, 2017
Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancerDi Zhao, Xin Lu, Guocan Wang, et al.
Nature Genetics|September 18, 2024
Spatial transcriptomic analysis of primary and metastatic pancreatic cancers highlights tumor microenvironmental heterogeneityAteeq M Khaliq, Meenakshi Rajamohan, Omer Saeed, et al.
Cancer Cell|May 19, 2010
PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomasHongwu Zheng, Haoqiang Ying, Ruprecht Wiedemeyer, et al.
Bioorganic & Medicinal Chemistry Letters|July 15, 2009
Respiratory syncytial virus fusion inhibitors. Part 7: structure-activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivoNy Sin, Brian L Venables, Keith D Combrink, et al.
Bioorganic & Medicinal Chemistry Letters|December 22, 2005
Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivoKuo-Long Yu, Xiangdong Alan Wang, Rita L Civiello, et al.
Nature|July 9, 2015
Corrigendum: Passenger deletions generate therapeutic vulnerabilities in cancerFlorian Muller, Simona Colla, Elisa Aquilanti, et al.
Cancers|July 24, 2021
Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal CancerDelphine Dayde, Jillian Gunther, Yutaka Hirayama, et al.
Nature Chemical Biology|October 11, 2016
SF2312 is a natural phosphonate inhibitor of enolasePaul G Leonard, Nikunj Satani, David Maxwell, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
Orally active fusion inhibitor of respiratory syncytial virusChristopher Cianci, Kuo-Long Yu, Keith Combrink, et al.
Pageof 19

Showing results (151-160 of 190) with videos related to

Sort By:
Pageof 19
Nature Communications|May 3, 2020
Effective combinatorial immunotherapy for penile squamous cell carcinomaTianhe Huang, Xi Cheng, Jad Chahoud, et al.
Nature|February 7, 2017
Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancerDi Zhao, Xin Lu, Guocan Wang, et al.
Nature Genetics|September 18, 2024
Spatial transcriptomic analysis of primary and metastatic pancreatic cancers highlights tumor microenvironmental heterogeneityAteeq M Khaliq, Meenakshi Rajamohan, Omer Saeed, et al.
Cancer Cell|May 19, 2010
PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomasHongwu Zheng, Haoqiang Ying, Ruprecht Wiedemeyer, et al.
Bioorganic & Medicinal Chemistry Letters|July 15, 2009
Respiratory syncytial virus fusion inhibitors. Part 7: structure-activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivoNy Sin, Brian L Venables, Keith D Combrink, et al.
Bioorganic & Medicinal Chemistry Letters|December 22, 2005
Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivoKuo-Long Yu, Xiangdong Alan Wang, Rita L Civiello, et al.
Nature|July 9, 2015
Corrigendum: Passenger deletions generate therapeutic vulnerabilities in cancerFlorian Muller, Simona Colla, Elisa Aquilanti, et al.
Cancers|July 24, 2021
Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal CancerDelphine Dayde, Jillian Gunther, Yutaka Hirayama, et al.
Nature Chemical Biology|October 11, 2016
SF2312 is a natural phosphonate inhibitor of enolasePaul G Leonard, Nikunj Satani, David Maxwell, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
Orally active fusion inhibitor of respiratory syncytial virusChristopher Cianci, Kuo-Long Yu, Keith Combrink, et al.
Pageof 19